← Eichor
Condition: Advanced Gynecological Malignancies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Gynecological Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Phase 2 · 2 location(s) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT07448922Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies
EARLY_Phase 1 · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT07434284Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · 53 location(s) · Revolution Medicines, Inc. · NCT06128551A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Phase 1/Phase 2 · 81 location(s) · GlaxoSmithKline · NCT06796907Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06306170Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/Phase 2 · 21 location(s) · Revolution Medicines, Inc. · NCT05379985A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gyneco
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06769152Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Mod
Phase N/A · 1 location(s) · Hua Li · NCT06232213A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
Phase 2 · 31 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06798207Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Phase N/A · 1 location(s) · Viome · NCT04957511A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
Phase 2 · 1 location(s) · Shanghai Hengrui Pharmaceutical Co., Ltd. · NCT06654440Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
Phase 1 · 1 location(s) · University Health Network, Toronto · NCT06977126Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Phase N/A · 7 location(s) · University Health Network, Toronto · NCT02906943A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors
NA · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT06904131Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Phase 2 · 49 location(s) · Corcept Therapeutics · NCT06906341
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.